Martin George Kelly's Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Sep 10, 2024
- Accession no.
- 0001415889-24-023167
- Filed
- Sep 10, 2024
- Trade date
- Aug 28, 2024
- Filing delay
- 13 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $49.5. It was filed 13 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Martin George KellyCIK 0001982607 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Common Stock | SSaleDisposed | −9 | $5.50 | −$49.5 | 247,176 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.